Affinivax Announces Collaboration with ClearPath and Astellas to Develop Vaccines to Prevent Nosocomial Infections
Jackson Laboratory Spinout Cyteir Therapeutics Announces $5.5 Million Series A Financing Round and Appointment of Donald F. Corcoran as President and Chief Executive Officer
Bristol-Myers Squibb and LabCentral Team Up in Cambridge, Massachusetts to Support Promising Biotech Startup Companies
Yumanity Therapeutics Closes $45 Million Series A Financing
Unum Therapeutics Moves to New Headquarters in Cambridge, MA as It Continues to Expand and Advance its Cellular Immunotherapy Pipeline
Aquinnah Pharmaceuticals Receives $5 Million Investment from Takeda Pharmaceuticals To Advance New Therapies in ALS
Arsia Therapeutics Inc. and Biogen Sign a Research Collaboration for the Development of Subcutaneous Biologics
Navitor Pharmaceuticals Announces $33 Million Series B Financing
Unum Therapeutics Announces Recombinant DNA Advisory Committee’s (RAC) Unanimous Approval of Phase 1 Study Protocol to Evaluate ACTR Cell Therapy in Non-Hodgkin Lymphoma
Aquinnah Pharmaceuticals Receives $680,000 Grant from NINDS To Advance New Therapies for ALS
